Celularity annual gross margin
2020
2021
2022
2023
Celularity's gross margin was 29.66% for fiscal 2023.
View full Celularity company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | 29.66% | +39.07 pp |
| 2022 | 2022-12-31 | −9.40% | −64.16 pp |
| 2021 | 2021-12-31 | 54.76% | −10.70 pp |
| 2020 | 2020-12-31 | 65.46% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2023 | 2023-12-31 | 20.67% | +47.74 pp |
| Q3 2023 | 2023-09-30 | 4.86% | +79.30 pp |
| Q2 2023 | 2023-06-30 | 72.70% | +56.89 pp |
| Q1 2023 | 2023-03-31 | 49.10% | +16.93 pp |
| Q4 2022 | 2022-12-31 | −27.08% | −31.11 pp |
| Q3 2022 | 2022-09-30 | −74.44% | −152.68 pp |
| Q2 2022 | 2022-06-30 | 15.81% | −39.15 pp |
| Q1 2022 | 2022-03-31 | 32.17% | −21.14 pp |
| Q4 2021 | 2021-12-31 | 4.04% | −65.17 pp |
| Q3 2021 | 2021-09-30 | 78.24% | — |
| Q2 2021 | 2021-06-30 | 54.96% | — |
| Q1 2021 | 2021-03-31 | 53.31% | — |
| Q3 2020 | 2020-09-30 | 69.21% | — |
Across the available reported history, Celularity's gross margin increased from −9.40% to 29.66%, a change of +39.07 percentage points. The latest reported quarter, Q4 2023, shows 20.67%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Celularity filings at SEC.gov ↗